A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis

NCT01081782 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

407

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: ONO-4641
DRUG: ONO-4641
DRUG: ONO-4641
DRUG: ONO-4641 placebo

Sponsor

Ono Pharma USA Inc